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Abstract
Background: This is a study involving three HIV clinics in the Canadian provinces of Newfoundland and Labrador,
and Manitoba. We sought to identify ethical issues involving health care providers and clinic clients in these
settings, and to gain an understanding of how different ethical issues are managed by these groups.
Methods: We used an institutional ethnographic method to investigate ethical issues in HIV clinics. Our researcher
conducted in-depth semi-structured interviews, compiled participant observation notes, and studied health records
in order to document ethical issues in the clinics, and to understand how health care providers and clinic clients
manage and resolve these issues.
Results: We found that health care providers and clinic clients have developed work processes for managing
ethical issues of various types: conflicts between client-autonomy and public health priorities (“treatment as
prevention”), difficulties associated with the criminalization of nondisclosure of HIV positive status, challenges with
non-adherence to HIV treatment, the protection of confidentiality, barriers to treatment access, and negative social
determinants of health and well-being.
Conclusions: Some ethical issues resulted from structural disadvantages experienced by clinic clients. The most
striking findings in our study were the negative social determinants of health and well-being experienced by some
clinic clients – such as experiences of violence and trauma, poverty, racism, colonization, homelessness, and other
factors affecting well-being such as problematic substance use. These negative determinants were at the root of
other ethical issues, and are themselves of ethical concern.
Keywords: Adherence, Bioethics, Clinical ethics, Confidentiality, HIV, Institutional ethnography, Nondisclosure,
Social determinants
Background
AIDS emerged in the 1980’s as a novel illness and life-
threatening disease. Because of the combination of the
severity of disease, its transmissibility, and discrimination
against the groups most affected by HIV, the emergence
of AIDS gave rise to many challenging clinical ethics is-
sues. Intense debates about the refusal of care played out
in medical ethics journals and amongst the membership
of professional groups such as doctors and nurses [1–5].
The protection of confidentiality became a conten-
tious issue [6, 7]. Physicians and other caregivers
wondered about their duty to warn third parties who
might be at risk because of the activities of patients
they knew were HIV-positive [8, 9]. Clinical ethics is-
sues intersected with research ethics issues [7, 10] as
well as with public health strategies for managing in-
fectious disease outbreaks [11, 12].
The late 1990’s brought new treatments in the form of
anti-retroviral therapy (ART), particularly the advent of
protease inhibitors [13]. These treatments have changed
the experience of living with HIV for many people, and
have also altered the way HIV is perceived. ART has ex-
tended the lives of many who are living with HIV. Death
rates declined and many people living with HIV were
able to manage it as a chronic infection. The experience
of HIV as a chronic infection is dependent upon contin-
gent factors that affect access to treatment [14–19]. But
even when it is managed as a chronic illness, HIV care
presents its own challenges. This article discusses
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present-day clinical ethics issues in HIV care in Canada.
In the context of a larger project examining the shift in
HIV care from specialist to primary care environments,
we asked people living with HIV as well as their health
care providers about the quality of their care, successes,
difficulties, and sources of conflict. The objective of our
study was to investigate and document clinical ethics is-
sues experienced in HIV care.
Recent clinical ethics literature on HIV addresses a variety
of themes. Among these are the criminalization of failing to
disclose HIV positive status to sexual partners [20–25]; the
recent push to treat HIV with ART as a way of preventing
transmission, known as “treatment as prevention”, which
can cause a conflict between duties to the patient versus
public health priorities [26–31]; and adherence1 to ART
among members of vulnerable groups [32–36]. In our
study we gave research participants opportunities to discuss
these ethical issues in particular, as well as any others they
may have experienced. We therefore sought to determine
whether some of the more prominently discussed ethical is-
sues in HIV care are actually occurring in the HIV clinics
we studied, and to determine what other ethical issues
might affect day-to-day care.
Methods
Institutional ethnography
This study utilized an institutional ethnography (IE)
methodology. IE is a method for studying the social
relations that shape and organize everyday experience
[37–40]. The focus in IE is not so much on the individ-
ual participant in the study as it is on “the social” itself,
understood as the ongoing structural and social determi-
nants of everyday activity [35]. These determinants in-
clude institutional work processes – the implicit norms,
and explicit rules of daily work that organize activity. In
our study, the “work” in question is defined broadly to
include both the work of health care providers involved
in the clinical and social care of people living with HIV,
as well the health work contributed by people living with
HIV themselves devoted to their own care [35]. The IE
researcher Liza McCoy states that “[t]he health care of a
person living with HIV involves a complex, daily work
process that loops from the home and everyday spaces
of the individual into the sites of professional medical
service and back again” [34].
We investigated the work performed by both groups
(health care providers and clinic clients2) – work that in-
volves managing, responding to, and occasionally provok-
ing ethical issues in clinical care for HIV. IE exposes the
institutional orders, power imbalances, and social factors
at play in coordinating this work. The institutional order
in which work is performed often consists of activities di-
rected by textual materials [41]. In our study these influ-
ential texts included Supreme Court of Canada rulings,
provincial government legislation, professional guidelines,
and published research findings. IE is a method that at-
tends to these texts and traces out their influence on
everyday activities. The relations instituted by such texts
are “translocal” in nature – they extend across local con-
texts and standardize activities in multiple settings. Every-
day processes of treating HIV in a clinic and of managing
one’s health are implicated in organizational effects that
originate from beyond the everyday setting. The goal of IE
in this study was thus to assemble the health work experi-
ences of those involved with ethical issues in HIV care,
and to display how these experiences are coordinated –
socially, locally, and translocally [41].
Description of our study
Our institutional ethnography researcher worked in the
field for one year at three different HIV clinics – one in
the Canadian province of Newfoundland and Labrador
(NL), and two in the province of Manitoba (MB). The
clinic in Newfoundland and Labrador is based in the city
of St. John’s, which is a small urban centre with a popula-
tion of about 200 000 people. The St. John’s clinic is the
only HIV clinic in the province. Both clinics in Manitoba
are based in the capital city of Winnipeg, which is a mid-
sized urban centre of just under 700 000 people. All clinics
in the study serve a mix of urban, suburban, and rural res-
idents. The geographic diversity of the populations served
by the clinics in our study was a desirable feature, since
we sought to capture ethical issues affecting people living
with HIV both within and outside of urban areas. Each
clinic in our study also has substantial numbers of female
patients – in Newfoundland and Labrador these were
often women living in nonurban areas, and in Manitoba
many participants were Indigenous women.
Our researcher observed and interacted with health care
providers and clinic clients over a period of 5–6 months
in each clinic. She documented clinical interactions be-
tween providers and clients, conducted interviews with
members of both groups, examined medical records, and
analyzed textual materials. The researcher read through
medical chart notes, copies of correspondence between
physicians and patients, and between primary care pro-
viders and specialists. She studied a large number of docu-
ments such as clinic and professional policies on the use
of ART, therapeutic guidelines for the treatment of HIV in
primary care, guidelines on the management of co-
infection, job descriptions, communicable disease surveil-
lance reports, the results of internal quality-improvement
initiatives such as a patient satisfaction survey, and other
relevant materials.
The interviews were semi-structured in nature, with op-
portunity for the researcher to probe topics further and
pose follow-up questions. We interviewed a total of 22
people living with HIV, and 20 health care providers,
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including primary care physicians, infectious disease spe-
cialist physicians, clinic nurses, nurse practitioners, clinic-
based and community-based social workers, pharmacists,
and others. We sought to include any health care worker
involved in the health or social care of people living with
HIV who attended one of the clinics in our study.
Amongst the clinic clients living with HIV, our re-
searcher interviewed and interacted with people from
many social locations – including gay, bisexual, and het-
erosexual men, men and women living in rural areas and
urban centres, Indigenous3 men and women, people with
a history of injection drug use, affluent people and people
living below the poverty level including people who are
homeless, and people with physical disabilities. We in-
cluded any adult living with HIV who attended the clinics
in our study, and only excluded potential participants on
the basis of inability to consent to participation. We sam-
pled purposively in order to introduce as much diversity
as possible in the group of people living with HIV in-
cluded in our study. Clinic clients were contacted in vari-
ous ways to request their participation. Some volunteered
after seeing advertisements for our study in clinic waiting
areas, or after hearing about the study through word-of-
mouth. In other cases, health care providers told clients
about the study during clinic visits and were directed to
our researcher to discuss participation.
During interviews with clinic clients our researcher
asked general questions about what is going well with
their HIV care, what could be improved, what changes
might have occurred in the management of their HIV
over time, and about how much they feel involved in de-
cisions about their care. We also asked targeted ques-
tions about how they manage disclosing their HIV
positive status with family, friends, and intimates, as well
as questions about any barriers they experience with ad-
herence to ART, and how their health care providers
interact with them on adherence issues. With such ques-
tions we sought to uncover any ethical issues clinic cli-
ents had experienced.
Our researcher asked health care providers general
questions about challenges they face in providing clinical
care for people living with HIV, as well as questions
about what ideal care would look like. She asked for
their thoughts on the “treatment as prevention” para-
digm. The interviews with health care providers also in-
cluded questions about how they work with clinic clients
on the issue of disclosing their HIV positive status to
sexual partners, about how they manage legal issues in
their work, and about challenges with adherence to
ART. In this way, the interview questions included a mix
of general probes meant to uncover ethical issues, as
well as specific inquiries about issues that are prominent
in recent ethics literature on the clinical care of people
living with HIV.
Our researcher compiled participant observation notes
during clinic interactions between health care providers
and clients, and between care team members themselves.
She observed patient appointments with care teams and
with individual health care providers in which care plans
were discussed. Each appointment lasted about 45 min.
The researcher also participated in formal and informal
meetings between health care providers of varying dur-
ation. She attended to the ways in which clinic clients
were involved in decision-making, the dynamics of com-
munication, and any instances of difficulty or misunder-
standing experienced by clinic clients or their health
care providers. Similarly, in her review of patient re-
cords, the researcher noted how professionals communi-
cated with each other through letters or charts, and any
care challenges documented in this medium. These
sources of information were used to examine and trace
out the relations between professionals, and between
health care providers and clinic clients.
All interviews were audio recorded and transcribed. The
transcripts along with field notes based on clinic observa-
tions and on patient medical records were made available
to the data analysis team. This team consisted of a multi-
disciplinary group including the ethnographic researcher
herself, and others with expertise in clinical ethics, institu-
tional ethnography, qualitative research, health services
research, and the clinical care of people living with HIV
and of marginalized populations. We embedded verifica-
tion of our results into the study design through the
constitution of our analysis team as an intersubjective
multi-expert group [42]. Each member of the analysis
team read through transcripts, observations notes, and
relevant documents independently. We convened a series
of meetings over several months to discuss the ethical is-
sues that we each found being discussed or depicted in
the data. Through the analysis of data, we identified a
series of clinical ethics issues in HIV care experienced by
study participants. Each team member compiled a de-
scriptive list of ethical issues they found in the data. Dur-
ing our meetings, and in the drafting of this article we
arrived at a discursive consensus about the ethical issues
that emerged in our study, and about the important social
and institutional factors contributing to these issues. We
sought to catalogue these issues and to trace out the rela-
tions (social, textual, local, translocal) that play a role in
making them ethical issues. Data “saturation” was evi-
denced by the thematic coherence across our sources of
data that we found upon analysis.
The concept of “ethical issue” in the clinical setting
can be interpreted variably. We encouraged our study
participants to discuss any issue they saw as ethical in
nature, in order to avoid excluding any issues that could
possibly be relevant. However, in our analysis we have
included, amongst the clinical ethics issues in our
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findings, those issues that health care providers and
clinic clients devote work processes to resolving. These
issues can often be described as dilemmas between the
classical ethical principles of respecting autonomy, ben-
eficence, nonmaleficence, and justice. Our goal was to
describe the clinical ethics issues we encountered in the
data and the work processes that research participants
devoted to the management and resolution of these is-
sues. We acknowledge that ethical issues in the clinical
setting have their roots in, and are complexly entwined
with, poverty, racism, oppression, and other problems of
social and institutional structures faced by clinic clients
and care providers. These social problems are not always
easy to describe using the language of clinical ethics
principles. Though we have not described the social de-
terminants of health and well-being as themselves clin-
ical ethics issues, we account for these determinants as
causes and contributing factors to such issues.
Results
As we have discussed, there were a number of ethical is-
sues about which we had pre-planned questions in our
interview guides. There were also other ethical issues
that emerged out of general questions about quality of
care, communications, and the like. We organize our
discussion of results with the former type of ethical is-
sues presented first, and with the latter type of ethical
issue following.
Treatment as prevention versus respect for autonomy
The treatment as prevention paradigm is premised on
the idea that using ART in the treatment of people who
are newly diagnosed with HIV as soon as possible, redu-
cing their viral load, and maintaining viral suppression,
will also reduce the likelihood that the diagnosed person
will transmit HIV to others [43]. Viral suppression re-
duces transmissibility [44]. Over time, the reduction of
the number of people within the population who are in-
fectious could effectively stop HIV from spreading.
Combined with an expansion of testing and identifica-
tion of people living with HIV, the treatment as preven-
tion paradigm could be an effective way of controlling
HIV within a population.
From a clinician’s point of view, the public health inter-
est in controlling the spread of HIV within the population
at large through the treatment as prevention strategy
could set up a conflict between a clinician’s duty to the cli-
ent, and his or her duty to the health of the public [31].
On the one hand, there is a duty to respect a client’s in-
formed consent about initiating or refusing treatment,
such as ART. On the other hand, a client’s refusal might
run counter to the public health interest in reducing the
viral load of all clients as a way of reducing the likelihood
of transmission. Pushing treatment as prevention on a
patient in the interests of public health could thus violate
the client’s informed consent [28]. This dynamic could
create a dilemma between the obligation to respect the au-
tonomous refusal of care versus a health care provider’s
duty of beneficence towards the health of the public.
In our study, we asked health care providers their
thoughts about treatment as prevention. In general,
health care providers reported that they defer to the cli-
ent’s informed consent. They recommend initiation of
ART based on clinical guidelines, but also respect re-
fusals of treatment. Consider the following exchange
Health care provider (HCP): … the guidelines now are
saying you just offer it…
Interviewer (I): And that’s the guidelines. And there’s
nothing you can do.
HCP: Yeah, it’s up to them [the clients] … Most
people choose to take them [ART] … Because the
literature now is that the sooner people start the
better their immune system is…
I: Right. So this idea that even if you don’t need it
right now to boost your immune system you may
have some protective effects because of it.
HCP: Yeah. So we didn’t look at it as a community
health thing. We look at it from the patient’s
perspective.
I: And if they’re not interested in going on treatment …
HCP: That’s up to them. (health care provider, NL)
The health care providers involved in our study tended
to see the benefits of ART for preventing transmission.
Even more importantly, however, they were comfortable
recommending the initiation of ART because of per-
ceived benefits to the client. Thus, health care providers
who participated in our study reported that they give
priority to the client’s informed consent over the public
health benefits of treatment as prevention.
Prior to the development of guidelines supporting the
early initiation of ART, there was no professional con-
sensus in favour of this practice [45]. In the exchange
quoted above, the health care provider suggested that
the norms underlying this approach to treatment arose
from published research demonstrating the benefit of
early initiation of ART, and from subsequent changes in
the treatment guidelines. There is also a strong medico-
legal injunction underlying virtually all clinical encoun-
ters that informed treatment refusals must be respected.
Criminalization of HIV nondisclosure
In 1998 the Supreme Court of Canada set a precedent for
the conditions under which a person who is HIV positive
can be found guilty of a crime, such as assault, as a result
of failing to disclose his or her HIV positive status to a
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sexual partner. This ruling (R. v. Cuerrier) stated that such
a person is guilty if he or she was dishonest about being
HIV positive through lying or failing to disclose, and if this
dishonesty resulted in “significant risk of serious bodily
harm” through sexual contact [22, 46].
In 2012 further Supreme Court of Canada rulings in R.
v. Mabior/R. v. D.C. clarified the previous precedent. In
these cases the Supreme Court specified that if the person
has a low viral load and uses a condom, then there is not a
realistic possibility of transmission and no significant risk
of serious bodily harm, so failing to disclose that one is
HIV positive is not a criminal act [47, 48]. However, a low
viral load, but with a failure to use a condom, and a failure
to disclose that one is HIV positive, was deemed a signifi-
cant risk of serious bodily harm, and was therefore judged
a criminal act. This judicial interpretation of the level of
risk runs contrary to current scientific evidence and expert
opinion [49]. These rulings suggest that even condom use
is not enough to avoid prosecution for nondisclosure. One
must also have a low viral load to avoid criminal charges
for failing to disclose, though what constitutes “low” viral
load was not defined by the court.
These rulings have clinical ethics implications for people
living with HIV, and for their health care providers. If a
clinic client is arrested or charged with a crime because of
nondisclosure, medical records could become subject to
subpoena, and health care providers could become wit-
nesses or could be called to testify in a criminal proceed-
ing. These possibilities could influence the counselling
practices of health care providers and the experiences of
clinic clients [25]. The Supreme Court rulings could deter-
mine the information health care providers impart to cli-
ents, and the introduction of legalities into the clinical
relationship could influence the level of trust and the qual-
ity of the information that is shared. These legal rules
could affect a health care provider’s ability to comply with
the ethical duty of nonmaleficence. Furthermore, factors
such as Supreme Court rulings, counselling practices, and
levels of trust, have the potential to affect the intimate sex-
ual practices of people living with HIV, their feelings of
fear, self-worth, and safety.
We asked clinic clients in interviews about their dis-
closure practices, and about any legal concerns they had
related to their HIV status. We also asked health care
providers about legal issues they had encountered. Both
groups of participants brought up the criminalization of
nondisclosure in response to these questions. Criminal
cases involving nondisclosure were familiar to many re-
search participants in both groups. In Newfoundland in
1993, a man named Raymond Mercer had been found
guilty of endangering the lives, safety, or health of the
public because he transmitted HIV to two women via
unprotected sex [50]. Mercer had failed to disclose that
he was HIV positive to these women. He was sentenced
to eleven years and three months in jail [50]. When we
asked research participants in Newfoundland about their
awareness of the nondisclosure issue, several health care
workers and clinic clients mentioned the Mercer case.
In general, the clinic clients living with HIV we inter-
viewed stated that they have a personal policy of disclosing
their HIV status to all sexual partners. The disclosure
process can happen in various ways – verbally of course,
but also through information provided on internet dating
sites, or through apps designed to help people find sexual
partners. One clinic client described his disclosure prac-
tices in this way:
There’s one that’s actually pretty exclusive for HIV:
barebackRT.com … in the biography the little bio it will
say “positive don’t care”, “negative” then you’ll say who
you look for, like you look for negative only, positive
only … That one kind of keeps you out of trouble if you
want to just hook up with positive guys or undetectable
– whatever you’re looking for. If you’re on Grindr,
Grindr is not bad but actually it tells you what your
little tribes are and you can put whatever type of
people: bears, twigs and you can even put positive in
there too you know. (clinic client, MB)
As this research participant pointed out, disclosure
practices are often embedded in, and are mediated
through technology. The Supreme Court rulings, of
which virtually all research participants seemed to be
aware, play a role in organizing these practices toward a
fairly standard position of disclosing to sexual partners.
Other studies have discussed the difficulties associated
with disclosing that one is HIV-positive [22], though the
participants in our study tended not to highlight these
difficulties in their own experiences.
From the perspective of health care providers, many
noted that their work practices involve counseling clinic
clients about the law regarding disclosure, and that they
also make an effort to involve spouses or other partners in
the counselling process, encouraging clinic clients to bring
them to appointments. One provider described her pro-
cedure: “We chart that we’ve made sure we told them the
disclosure laws. We chart that the first time we see them
to make sure that you know it’s documented or whether
or not they brought a partner in with them” (health care
provider, MB). Potential legal or ethical issues that might
arise as a result of nondisclosure are managed through
counselling early in the clinical relationship, involving
other potentially affected parties, and through textual
documentation on the client’s chart.
These attempts to manage the possibility of nondisclo-
sure themselves might have untoward effects. One clinic
client said that he was annoyed about being lectured by
his family doctor to disclose to every sexual partner, even
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though his viral load was undetectable and he always used
condoms. The doctor mistakenly informed this client that
he had a higher standard of responsibility (“always dis-
close”) than what is required by the Supreme Court of
Canada. As discussed above, the Supreme Court rulings
state that disclosure is not required when a person living
with HIV uses a condom and has a low viral load. In this
way the legal implications of HIV non-disclosure can in-
vade the client-provider relationship, impact the quality of
these relations, and confuse practical advice regarding the
prevention of HIV transmission.
Furthermore, sometimes nondisclosure occurs – an-
other potential untoward outcome. People fail to dis-
close for all sorts of reasons, and counselling may be
ineffective in preventing this from happening. A health
care provider described such a scenario:
the biggest [problem] would be probably to diagnose
somebody knowing that they got it from somebody
that I know. That was the biggest that I had to deal
with when, for example, you know the person, they’re
not on medication … They’re refusing. You tell them
to use condoms, they say they do but they don’t, and
then they end up with a boyfriend, and then the
boyfriend gets tested and they’re positive, and they
didn’t tell the boyfriend. So then you know the
background and the details but you can’t say it out
loud to the other person. (health care provider, MB)
On the one hand, the health care provider had a duty
to protect a client’s privacy regarding the client’s HIV
status. On the other hand, the health care provider had
information about probable harm to another person on
the part of the client who appeared to have transmitted
the virus to a boyfriend. But sharing this information
with the boyfriend would be a striking breach of confi-
dentiality, and the legal implications of HIV nondisclo-
sure increase the potential for harms to the client.
Nonetheless, ongoing nondisclosure by the client could
result in harm to others. The health care provider man-
aged the ethical difficulty posed by a client’s failure to
disclose by maintaining the client’s confidentiality.
Other health care providers described physicians and
nurses in their clinic becoming involved in court pro-
ceedings over nondisclosure, and another recounted be-
ing contacted by police about a suspected nondisclosure
case and refusing to provide information without being
given a warrant.
We have presented a number of ways in which nondis-
closure is managed in the clinic – for example through
counselling, or protecting confidentiality when this is le-
gally possible. One further method for managing the
nondisclosure issue is through documentation. However,
this method can have unintended effects. A health care
provider outlined a way criminalization might encourage
the spread of HIV:
I think people have put off, you know, getting tested
though because they do have very risky unprotected
sex and I think they put off being tested so that it’s
not on paper that they’re diagnosed so they can
continue their behaviour. (health care provider, MB)
In this case, the consequences resulting from being doc-
umented as HIV positive were understood as a deterrent
to testing and accessing treatment. This health care pro-
vider believed that some people might be afraid of being
denoted HIV positive “on paper” because such a notation
could force a change in behaviour. Criminalization could
impede the realization of public health goals if HIV is
spread because of this fear.
In summary, clinic clients involved in our study de-
scribed a personal policy of disclosure as a way of pre-
venting legal problems related to nondisclosure. Health
care providers managed the nondisclosure issue through
counselling and documentation.
Adherence to treatment
One of the chief obligations of health care workers to their
patients and clients is to provide benefit – otherwise known
as the duty of “beneficence”. Care providers might believe
that they have failed in this ethical duty if the treatment
they offer is not successful. But success in the treatment of
HIV often depends on adherence to ART – which requires
the participation of both provider and client in the health
work of HIV care [35]. Sometimes, for various reasons,
people do not successfully adhere to treatment.
[T]he people … I have the most consistent interaction
with are actually the folks who are nonadherent. So
they surface, you know, and I do all kinds of stuff with
them to get their medications again and see them and
talk to them about adherence – not about adherence
but about their lives to see what we can work out
together – and then they’ll disappear for a while … I
used to have more of them but a lot of those folks
over time actually died. (health care provider, NL)
Many participants, clinic clients and health care pro-
viders alike, gave accounts of the difficult, ongoing, par-
ticipatory health work of maintaining adherence. Many
described the hard work of maintaining trust and prob-
lem solving around side effects, housing issues, addic-
tions, education about HIV and how ART works, and a
myriad of other factors that affect adherence. It may be
difficult to accept that you have fulfilled your ethical du-
ties of beneficence when these efforts are for nought and
your clients die.
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Nonetheless, all of the evidence in our data suggests that
the health care workers who described these efforts are
highly beneficent. All health care providers in our study
tended to adopt a policy of trust and deference toward the
personal choices of clients, even if this policy resulted in
nonadherence. They tended to be noncritical, and to ap-
proach the issue from a constructive problem-solving per-
spective, while continuing to encourage adherence.
In the clinical context, one way of managing the issue
of adherence is through monitoring and questioning the
client. At every appointment, health care providers asked
clients about whether they had missed their medications,
and followed up if blood work indicated less than ad-
equate adherence to ART. The development of resist-
ance to different treatment regimens often requires
changes or adjustment to medication, so keeping watch
over adherence is a necessary clinical practice. Nonethe-
less, some clinic clients expressed annoyance about this
questioning. One client described the dynamic in the fol-
lowing way:
It has everything to do with stigma … like it is my job
to be a good, behaving, positive person always going
for blood work, always adhering to their medication
because I hesitate to tell my doctor if I sometimes
miss my meds. You know I hesitate to tell them like
it’s a pain in the butt that I have to alter my life so I
can come in for blood work once every five or six
months. (clinic client, MB)
This clinic client linked the questioning about adher-
ence with HIV stigma. The participatory nature of health
work can produce tension if there is an implicit assump-
tion that people living with HIV must adhere to treat-
ment – or “behave”. It may be difficult to maintain trust
in such circumstances. While the health care providers
in our study maintained an attitude of respectful
problem-solving in the management of adherence, these
interactions can still exhibit ethical tension.
Protecting confidentiality
We have already touched on the protection of confiden-
tiality as a way of dealing with nondisclosure situations
in the clinic. The topic of confidentiality also emerged in
our study as an ethical issue in two other important
ways. Unlike the ethical issues discussed earlier, we had
no specific questions in our interview guides that
prompted participants to discuss confidentiality.
The first example relates exclusively to the clinic in
Newfoundland. This clinic had features in its built envir-
onment and policies for scheduling appointments that
were designed to ensure that patients coming for visits
did not come into contact with each other. Clinic ap-
pointments were spaced out one client at a time, and
waiting areas were organized so that waiting clients
would not be able to see other clients leaving, and would
not come into contact with other people who were in
the building for other reasons. According to one health
care provider, these measures were put into place at the
request of a number of clients who were unhappy with a
previous arrangement in which they had to wait for ap-
pointments in a common area with clients for other
clinics: “they didn’t like being set in the room because
they felt all eyes were on them, that they knew that’s
why they were there” (health care provider, NL). Even
with the new arrangement, some clients went to great
lengths to avoid contact. A health care provider de-
scribed one particular client as:
one of these ones who sneaks in the back door, calls
me when he’s outside, “All right, I’m on my way up
just be waiting for me, make sure there’s nobody
there,” won’t get his blood work done [in the lab] and
he’ll come up here [to the clinic] and get his blood
work done, won’t go anywhere else. He’s one who I’ve
actually had to go to his home and drew blood work
because he didn’t want to come in. (health care
provider, NL)
Part of the explanation for this concern around main-
taining privacy is that Newfoundland and Labrador has
a small population (only about 500 000 people), and it is
relatively likely for a client to see someone he or she
might know while waiting for an appointment – “some-
body knows somebody who knows somebody, you
know” (health care provider, NL). The clinic in St. John’s
served people who live in rural areas, along with those
in urban and suburban areas of the city, and the experi-
ence of lacking privacy becomes magnified in small-
town or rural Newfoundland [51].
From one perspective, maintaining confidentiality by
sheltering HIV clinic clients from unwanted contact can
be seen as culturally competent care. Within a cultural
context with a heightened degree of HIV-stigma, homo-
phobia, or other intersecting biases, the protection of
confidentiality can be seen as an ethical virtue. However,
in a clinic with a diverse population of clients, not all
have the same values or culture. Some research partici-
pants saw the measures used to protect confidentiality
as “perpetuating the stigma” (clinic client, NL). Accord-
ing to this reasoning, there is fear about being known as
HIV positive only because HIV is a stigmatized illness.
Thus, excessive privacy measures only accommodate
stigma, when stigma should instead be challenged with
openness or normalization. One research participant ar-
gued that there was a downside to privacy measures that
“push the stigma”. He speculated that, “There are prob-
ably another 500 cases in Newfoundland that haven’t
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been detected because of that” (clinic client, NL). In his
view, a reluctance to get tested for HIV results from the
perpetuation of HIV-stigma.
This disagreement between the values of clinic clients
created a dilemma for health care providers and their
managers. Satisfying the request for enhanced protec-
tions for confidentiality means, at the same time, being
unable to satisfy those who want more openness as a
challenge to stigma, or to enable community connec-
tions to form in the clinic setting. Clinic workers thus
face a dilemma between the duty to protect confidential-
ity versus a version of the duty of beneficence that in-
cludes confronting stigma. The health care workers in
our study were aware of the issue, and they managed the
dilemma by deferring to the clients who prefer greater
anonymity – who do not want to be circumstantially
identified as living with HIV.
Our second example of confidentiality as an ethical
issue in our study likewise involved life in rural areas. The
clinics in Manitoba also serve people living in rural areas
of the province – small towns and Indigenous communi-
ties. Confidentiality can be easily compromised when
medications are shipped to nursing stations, where all
health care is coordinated in these isolated and rural areas.
Several health care providers noted that nursing stations
often have community members on staff or hanging
around who might be able to see medications being deliv-
ered. The fear of HIV is so great in some communities
that people have been ostracized because of their HIV sta-
tus. A health care provider noted that, “it happens. We’ve
had people that have to endure terrible situations in their
home community and be isolated and leave. They leave”
(health care provider, MB). Similar problems arose around
the use of tele-health facilities in nursing stations where it
is difficult to maintain privacy during tele-consults.
A research participant described some measures for
maintaining client confidentiality in the shipping of
medication. She said that:
pharmacies, if they know that there’s issues of
confidentiality, they’ll do their best to be discreet
about putting them in a bag, you know, making sure
that the bag isn’t labeled out on the patient name, and
then … some have vans that will deliver them to the
patient. So there are ways to work around it. (health
care provider, MB)
Clinic personnel including pharmacists have developed
work processes designed to avoid the textual identifier
on a bag of medication that is a danger to the client.
The centralization of care in an urban centre away from
one’s home community, and HIV-related stigma can cre-
ate threats to maintaining confidentiality when care rela-
tionships extend from the urban centre to the rural area.
Access to medication
Canada has a universal, single-payer, health care system
for physician and hospital services. However, publicly-
funded health care does not extend to pharmaceutical
coverage outside of hospitals. Throughout the country
there is a great variety of Federal and Provincial govern-
ment programs, and private insurance plans that offer
some degree of prescription drug coverage, often tied to
employment or membership in certain groups. However,
there is no guarantee for citizens of either Manitoba or
Newfoundland and Labrador that one of these drug plans
will cover the total costs of ART. For those who do not
have 100% coverage through a private, Federal, or provin-
cial plan, each of these provinces offers a “catastrophic”
drug plan as a kind of last resort. These provincial plans
require payment of an annual deductible on a sliding scale
according to income. However, the deductible can be in
the thousands of dollars for people with even modest in-
comes of $30 000 or $40 000 a year [52, 53]. There are
further administrative requirements for applying to these
drug plans that can be an impediment or delay to access,
such as the requirement that applicants must provide in-
formation about their income from annual tax returns –
documentation that many people may not have. Our
interview guides did not contain specific questions about
financial or administrative barriers to ART access, but this
issue emerged as a prominent concern in our interviews
and other sources of data [54].
Because of the deductible, many people living with HIV
simply cannot afford ART. One clinic involved in our
study maintained a list of “at least 30” people who were
not receiving ART because they could not manage the
cost of the deductible (health care provider, MB). Consid-
ering that without treatment HIV is a life-threatening dis-
ease, this is a striking number of people for whom cost is
a barrier. Clinic clients recounted stories of people who
had delayed treatment with ART because they had not
filed tax returns for a number of years, and thus could not
apply for provincial drug coverage. One participant de-
scribed the horror he felt when he was told his annual de-
ductible would be $6000. Even when people living with
HIV can pay the deductible and access ART, the cost can
have an effect on their quality of life. In the clinical con-
text, poor coverage for ART makes it difficult for health
care providers to fulfill their duty of beneficence.
Health care providers and clinic clients outlined the
extensive participatory health work involved in getting
access to ART. One participant pointed out that, “every-
one needs a social worker when they go through that,
talking about our different programs, what’s your medi-
cation coverage” (health care provider, MB). The details,
requirements for drug coverage, and paperwork can be
quite complicated. A clinic client shared an anecdote
about the efforts his care team directed at resolving a
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dispute between a provincial drug program and his pri-
vate insurance:
So there’s a drug in my regime that is covered by [the
provincial plan] but only if the original [private
insurance] provider will not cover it. So when [the
private insurance plan] learned that, they refused to
cover the drug for me, and then [the provincial plan]
refused to cover the drug for me as well too, and I think
the overall cost is like $1500 a month or something
along those lines. So when that happened and I was
denied, they [the health care team] contacted [the private
insurance plan] directly for me and fought them. So I
was in the office when they were on the phone for a
good like two-and-a-half hours arguing with these guys
and then got it for me. (clinic client, NL)
In this story, securing access to a life-saving drug re-
quired a startling degree of advocacy to break the impasse.
Without such advocacy, an administrative barrier can
place the client’s health or financial well-being at risk.
Discussion
Similar studies
There is a wide variety of studies using IE and related
methodologies to research the health care experiences of
people living with HIV. These studies usually lack a focus
on clinical ethics issues, or tended to focus on only one of
the issues identified in our study. We have found no IE
studies whose purpose was the identification of clinical eth-
ics issues in HIV care, or the management of such issues.
Several studies have used IE to examine clinical relation-
ships in HIV care [34], the criminalization of HIV nondis-
closure [22], and the health-work of adherence from the
standpoint of people living with HIV [32, 35, 36, 55, 56].
Other studies have examined HIV care in other countries
using ethnographic methodologies or related qualitative
methodologies [57–61] though these studies do not tend
to focus on issues in clinical ethics. One exception is a
study of moral distress among Ugandan nurses who treat
patients with HIV that used a critical ethnographic
method [62]. A number of Canadian studies used qualita-
tive methodologies to examine the health care experiences
of people living with HIV [63–65]. One such article exam-
ining perinatal care in Canada for people living with HIV
identified the disregard of confidentiality as a negative care
experience [64]. Two recent Canadian studies used quali-
tative methodologies examine health care providers’ expe-
riences and perceptions of adherence to ART [66, 67].
The social determinants of clinical ethics issues
The issues of treatment as prevention [20–25], the
criminalization of nondisclosure [26–31], and ART adher-
ence [32–36] have been extensively discussed in recent
ethics and social science literature. In addition to these,
our study found that issues of confidentiality, and access
to ART are part of the everyday work of clinic clients and
health care providers in HIV clinics. As discussed in the
previous section, each of these ethical issues can manifest
in the form of clinical dilemmas in which ethical duties
come into conflict with one another. For example, health
care providers have duties to their clients that might con-
flict with duties towards the health of the public. The pro-
tection of confidentiality might conflict with efforts to
reduce stigma. These clinical dilemmas often have distal
causes outside of the clinic. The issue of access to ART re-
sults from social policy decisions made by provincial gov-
ernments and other ruling authorities beyond the clinic,
yet the effects of these decisions must be managed within
the clinic. Furthermore, the social determinants of poor
health and well-being experienced by some people living
with HIV were often contributing factors to ethical issues
in the HIV clinics.
The most overwhelming and lasting impression result-
ing from our study is that for many people living with
HIV, their social circumstances are a profound threat to
their health and well-being. Many research participants
documented instances of violence, racism, substance
use, poverty, homelessness, intergenerational trauma,
HIV stigma, homophobia, among other threats to health
and well-being. The most affected were clinic clients
who were homeless and experienced multiple forms of
structural disadvantage. As an example, a health care
provider described a client of hers:
she’s very complicated, she’s a solvent user, she’s
Aboriginal, very, very, very traumatized person, street
entrenched, sex worker, just lots of issues, injection
drug user. So she was not accessing care at all in any
consistent way for any reason. (health care provider,
MB, referring to clinic client)
Several clinic clients recounted stories of violence tied
to intergenerational trauma, colonization, and further cy-
cles of poverty, violence, and problematic substance use.
One said “my birth mother was constantly feeding me the
alcohol so I had no break” (clinic client, MB); another
“was with his birth mother when she was murdered or
committed suicide” (family member, MB referring to clinic
client). Out of three children the mother left behind he
“demanded the most attention screaming as a drug baby
[because] his mother was on cocaine and heroin” (family
member, MB referring to clinic client).
In the health care context, some of our research par-
ticipants reported being mistreated or being denied care
by health care providers because of their marginality. In
one example, a physician attempted to coerce a woman
into having an abortion when she was diagnosed as HIV
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positive. Another participant was denied care in an
emergency department when she had a facial fracture,
and suspected that the physician was motivated by ra-
cism, anti-HIV bias, disapproval of her substance use, or
all three factors. None of the instances of mistreatment
we heard about in our study related to care in any of the
HIV clinics in our study, but instead occurred in other
health care environments.
Social determinants of poor health and well-being can
contribute to becoming HIV positive, and can create diffi-
culties with maintaining care for HIV [68–71]. Data from
client health records in our study indicate that factors
such as being homeless and substance use correspond
with problems adhering to ART, and challenges with at-
tending clinic appointments. Protecting confidentiality is
identified as a challenge and a necessity, in part, because
of HIV stigma. Access to medication is an ethical issue be-
cause poverty, homelessness, and associated factors can
put ART out of reach. The criminalization of nondisclo-
sure, and treatment as prevention become complicated is-
sues when clinic clients have challenging everyday lives,
and experience structural disadvantage. Life circumstances
such as experiencing violence, trauma, or problematic
substance use issues are detrimental to health and well-
being even when not living with HIV. Social disparities
can contribute to the spread of HIV, and vice versa – a
phenomenon known as the theory of “syndemics” [70, 72].
The clinic clients in our study who were among the
most disadvantaged expressed a sense that mortality was
near. One client who was homeless said “I’m already
freaking dead anyway. You know what I mean? Kind of
like the walking dead” (clinic client, MB). When our re-
searcher offered to share the results of the study with
her at a future date, the participant said, “if I’m alive in a
year like I don’t know right”. Another participant won-
dered “like well how much time do I have left? Do I have
enough time to prepare for anybody to know like what’s
going to happen?” (clinic client, MB). A further research
participant said that he had been “noticing more and
more people who are HIV turning to crystal meth and
it’s usually only a couple of years they’re alive you know”
(clinic client, MB).
The health care providers in our study were aware of
these issues, and were constantly trying to help clients
with them. One participant who worked with especially
vulnerable clients explained that,
most of them struggle with future orientation … it’s
like they have a different priority. They live day to
day: they don’t care about what’s happening tomorrow
or in a couple of hours … like taking medications to
prevent them from getting sick in the future doesn’t
register … life is hard enough that they don’t really
care about HIV. (health care provider, MB)
When HIV is just one among many threats in one’s life,
and when there are more imminent dangers, seeking and
adhering to treatment for HIV may compete with more
immediate priorities, or may not be a priority. The social
context of living with HIV is often complex and, for
people living with multiple extreme social disadvantages,
their perspective on the work of managing HIV may be
different from the perspective of health care providers.
The ability to work towards future goals of health and
well-being may become compromised if it is hard to be-
lieve that one will live very far into the future. For some
people living with HIV who face such danger in their lives,
accessing care and adherence to ART may have less im-
portance than day-to-day survival. The fact that they live
in such peril is itself a significant ethical issue.
Many of the ethical issues we have examined have
their roots in translocal relations in which an external
authoritative text organizes behaviour in the clinic or
the local setting. For example, provincial government
drug programs – effected through legislation and regula-
tions – limit access to ART by requiring deductibles or
administrative requirements that cannot be met by some
people living with HIV. Supreme Court rulings influence
clinical behaviour and sexual behaviour by criminalizing
nondisclosure of HIV status. Nonetheless, though many
ethical issues are subtended by such translocal ruling re-
lations, we should not lose sight of the highly localized
nature of these issues. Local realities contribute to the
institutional order in which these ethical issues occur.
For example, some ethical issues we have discussed are
especially prominent within certain populations. Racism
and colonialism directed at Indigenous peoples can be a
barrier to care that is not experienced by other groups.
Problematic substance use can be a uniquely challenging
determinant of adherence to ART. Furthermore, some
ethical issues arise out of the local history of HIV. Het-
erosexual people living with HIV in rural Newfoundland
may have values and expectations of care that are differ-
ent from the values and expectations of urban gay men.
Such a conflict of values could be a source of the di-
lemma about how to manage issues of confidentiality in
the clinic. The organization of care at nursing stations in
remote Indigenous communities also gives rise to efforts
to protect confidentiality, as well as conflicts arising
from the colonial system of health care delivery. The ex-
perience of living with HIV is not uniform across
Canada. As such, we can expect that different local set-
tings will be faced with their own ethical issues.
Implications for practice
Health care providers and people living with HIV are
highly aware of the clinical ethics issues they face in
HIV care, and have developed norms and processes for
managing the issues that arise.
Kaposy et al. BMC Medical Ethics  (2017) 18:9 Page 10 of 13
 In the case of potential conflicts that arise out
of “treatment as prevention” efforts, health care
providers defer towards accepting the client’s
informed decision-making.
 Health care providers manage difficulties related to
the criminalization of nondisclosure through
counselling, documentation, and the protection of
confidentiality whenever possible. Clinic clients tend
to have adopted a norm of disclosure.
 Nonadherence is managed through perseverance
and a nonjudgmental approach.
 In situations in which confidentiality is at risk, the
clinics in our study have enacted procedures that
minimize the risk of breaches of confidentiality.
Conflicts between confidentiality and other values,
such as stigma reduction, are more contentious, but it
appears that the clinics have sought to preserve
confidentiality rather than endorsing another approach.
 Issues of access to HIV medications are managed
through determined advocacy by and on behalf of
clinic clients.
These findings do not translate into directives about
how to resolve ethical issues in HIV clinics. In a particu-
lar situation with circumstances that might be unique, a
more thorough normative analysis would be required in
order to determine whether a proposed resolution is eth-
ically justified. Nonetheless, our findings suggest a few
possible procedures and some common approaches
taken by people living with HIV and their health care
providers for resolving some common ethical issues en-
countered in HIV clinics in Canada.
The negative social determinants of health and well-
being that appear to be at the root of many clinical eth-
ics issues cannot be fully addressed or resolved in the
clinic and are translocal in nature. Improvements in the
lives of people living with HIV so that these issues are
addressed at their source will be a highly complex task,
requiring political change, structural interventions, and a
more just society.
Limitations
We cannot claim to provide a comprehensive account of
ethical issues in HIV care in Canada. The clinics we
studied are not representative of the Canadian popula-
tion. In particular, larger urban centres such as Toronto,
Montreal, or Vancouver were not represented in our
study. The fact that there is less ability for people to
choose between HIV clinics in small centres such as St.
John’s may have affected the ethical issues found in our
study of these centres. The clinics involved in our study
also tend not to be directed at serving specific popula-
tions, such as gay or bisexual men, for example. The
ethical issues in such population-specific clinics may be
different from what we have found in our study.
We attempted to capture a diversity of people living
with HIV among participants in our study. However, we
were unsuccessful in our attempts to include refugees or
migrants from areas in which HIV is endemic, or who
had been living with HIV prior to arrival in Canada.
A group of community scholars living with HIV provided
feedback on our research materials such as study design,
data access plans, and interview guides. However, this
group was small and could not, in any case, represent the
diversity of people living with HIV. We have attempted to
reduce the impact of observer bias by enabling a multi-
disciplinary group to conduct the data analysis, through the
use of textual materials available to all members of the ana-
lytical team, and verbatim transcripts of interviews for ana-
lysis. Nonetheless, the authorship group does not include
anyone with an Indigenous background, anyone living with
HIV, or representation from non-white ethnospecific
groups. These demographic factors may have influenced
our findings or analysis.
Conclusions
As has been discussed, we found evidence that people liv-
ing with HIV and their health care providers were man-
aging ethical issues in clinical care related to the
phenomenon known as treatment as prevention, the
criminalization of nondisclosure of HIV status, and adher-
ence to ART. We also found that both groups deal with
confidentiality issues, and problems with access to ART.
Several people living with HIV involved in our study who
experienced the most acute structural disadvantages
expressed an awareness of their imminent death because
of the dangerous circumstances of their lives. Clinical eth-
ics issues in HIV care occur within the context of these
negative social determinants, and this context arises from
outside of the clinic as part of the everyday experiences of
people living with HIV. Clinical interactions, including the
management of ethical issues, form part of the everyday
experience of poverty and social inequality.
Endnotes
1By “adherence” we mean “taking medication/undergoing
recommended treatment”. Some authors do not use the
term “adherence”, while others do. While the term “adher-
ence” is an improvement over the term “compliance” –
which implies that people are complying with orders or di-
rectives when undergoing treatment – we acknowledge that
some might not fully endorse the term “adherence” either.
2Throughout the article, we refer to people who are
living with HIV and accessing clinic care as “clinic cli-
ents” for the purposes of brevity. We acknowledge that
some prefer the terms “patients”, “consumers”, or “ser-
vice users” to describe those who access health care,
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while others find some or all of these terms problematic.
We have settled on the term “clients” since it seems the
least problematic, while we recognize that some people
might not like the term.
3Throughout the article, we use the term “Indigenous”
in relation to First Nations, Métis, and Inuit peoples in a
desire to maintain consistent terminology. We recognize
that the term “Indigenous” does not capture the diversity
of distinct histories, languages, cultures, and experiences
of the many First Nations, Métis, and Inuit peoples.
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